Core Viewpoint - Exact Sciences Corp. has launched the Cancerguard test, a new multi-cancer early detection blood test that is now available in the United States as a laboratory-developed test [1] Group 1: Product Launch - Cancerguard is the first commercially available multi-cancer early detection (MCED) test that analyzes multiple biomarker classes [1] - The test aims to help detect a wide range of cancers, including those that are often undiagnosed until later stages [1]